# Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery

> **NCT01294163** · PHASE3 · COMPLETED · sponsor: **Air Liquide Santé International** · enrollment: 509 (actual)

## Conditions studied

- Coronary Artery Disease
- General Anesthetic Drug Allergy
- Coronary Artery Bypass Graft Surgery

## Interventions

- **DRUG:** Xenon
- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT01294163
- **Lead sponsor:** Air Liquide Santé International
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 509 (ACTUAL)
- **Last updated:** 2015-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01294163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01294163, "Xenon Compared to Sevoflurane and Total Intravenous Anaesthesia for Coronary Artery Bypass Graft Surgery". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01294163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*